Acquisition · Professional & Local Services

Jubilant Ingrevia buys 40% stake in Zettaone Technologies

By Startup Enthusiast · 19 August 2026

What they do

Zettaone provides electronics design, prototyping, manufacturing and assembly services

Jubilant Ingrevia acquired a 40% stake for ₹189.2 crore in cash, in two tranches

The deal helps Jubilant Ingrevia enter the electronics development and manufacturing services space

Jubilant Ingrevia has acquired a 40% stake in Zettaone Technologies India Pvt Ltd.
The total consideration is ₹189.2 crore, paid in cash.
The acquisition will happen in two tranches: the first close by November 2026, the second by September 2027.
After the acquisition, Zettaone will become an associate company of Jubilant Ingrevia.
This move is part of Jubilant Ingrevia's 'Pinnacle growth strategy' to enter the EDMS (Electronics Development and Manufacturing Services) space.
Jubilant Ingrevia aims to combine its CDMO (Contract Development and Manufacturing Organisation) capabilities with Zettaone's electronics engineering for an integrated electronics/semiconductor value chain offering.

Zettaone was founded roughly two decades ago and has built capabilities from R&D, design, prototyping, manufacturing, assembly to box build.
The company serves sectors including aerospace, defence, semiconductor, automotive, medical, and industrial.
EDMS sector peers include Dixon Technologies and Amber Enterprises India.
Jubilant Ingrevia's share price was down 0.24% on the announcement day, but up 3.5% over the past year.

Zettaone is an electronics design and manufacturing platform.
Its capabilities span R&D, design, prototyping, manufacturing, assembly, and box build (final product assembly and testing).
It serves customers in aerospace, defence, semiconductor, automotive, medical, and industrial sectors.
Zettaone's turnover was ₹51.1 crore in FY24, ₹79.1 crore in FY25, and is projected at ₹98.1 crore for FY26.
Jubilant Ingrevia is a specialty chemicals and CDMO company with over 45 years of experience.
It has 130+ products, 6 manufacturing facilities in India, 50+ plants, 2300+ employees, and 3 R&D centres with about 150 scientists.
Jubilant Ingrevia serves customers in pharma, nutrition, agrochemical, consumer, semiconductor, and industrial sectors across US, Europe, Japan, Middle East, Southeast Asia, and India.

Jubilant Ingrevia plans to combine its CDMO capabilities with Zettaone's electronics engineering for an integrated electronics/semiconductor value chain offering.
The acquisition is part of Jubilant Ingrevia's 'Pinnacle growth strategy' to enter the EDMS space.